Barrington Research Cuts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Barrington Research reduced their Q1 2025 EPS estimates for shares of Henry Schein in a research report issued on Thursday, January 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $1.06 for the quarter, down from their prior forecast of $1.12. Barrington Research currently has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

Other equities research analysts also recently issued research reports about the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average price target of $80.10.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $80.00 on Friday. The firm has a market capitalization of $9.97 billion, a PE ratio of 32.92, a PEG ratio of 2.20 and a beta of 0.89. The stock’s fifty day moving average is $73.41 and its 200 day moving average is $71.46. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 earnings per share.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently made changes to their positions in the stock. ING Groep NV bought a new position in Henry Schein in the third quarter worth about $63,226,000. Holocene Advisors LP bought a new position in shares of Henry Schein during the 3rd quarter worth approximately $58,319,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Henry Schein during the 3rd quarter worth approximately $43,740,000. Southpoint Capital Advisors LP lifted its position in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Finally, Bank of Montreal Can boosted its stake in Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after acquiring an additional 558,689 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.